These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 5901012)

  • 1. Long-term study of oral contraception with norethindrone 2 mg. and mestranol 0.1 mg.
    Hutcherson WP; Schwartz HA; Weathers W
    Fertil Steril; 1966; 17(1):59-67. PubMed ID: 5901012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with ethynodiol diacetate and mestranol as an oral contraceptive.
    Gidwani GP; Purandare BN
    J Obstet Gynaecol India; 1968 Apr; 18(2):287-93. PubMed ID: 12331821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cyclic progestin-estrogen therapy on sebum and acne in women.
    Strauss JS; Pochi PE
    JAMA; 1964 Nov; 190(9):815-9. PubMed ID: 12254865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary stasis after mestranol-norethindrone ingestion. Report of a case.
    Sabel GH; Kirk RF
    Obstet Gynecol; 1968 Mar; 31(3):375-7. PubMed ID: 5639192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of oral contraceptive on the pituitary and plasma L.H. levels and on the hypothalamic LH-RH level (author's transl)].
    Sato N; Yanaihara T; Kanazawa M; Okinaga S; Arai K
    Nihon Naibunpi Gakkai Zasshi; 1976 Aug; 52(8):845-50. PubMed ID: 797581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Anovlar in gynaecological disorders and contraception.
    Shahani SM; Chiklikar A
    J Obstet Gynaecol India; 1968 Apr; 18(2):592-7. PubMed ID: 12331827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids.
    Stanczyk FZ; Brenner PF; Mishell DR; Ortiz A; Gentzschein EK; Goebelsmann U
    Contraception; 1978 Dec; 18(6):615-33. PubMed ID: 750188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative expressed estrogenicity of oral contraceptives.
    Rooks WH; Kugler SL; Dorfman RI
    Fertil Steril; 1968; 19(3):419-23. PubMed ID: 5647620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial changes induced by the administration of an oral contraceptive, norethindrone (S-3800B).
    Utsumi K; Kuribayashi N; Kumakiri S
    Acta Pathol Jpn; 1966 May; 16(2):141-50. PubMed ID: 6012525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenocortical function of patients using oral contraceptives.
    Kauppila A; Järvinen PA; Ylöstalo P; Reinilä M
    Acta Obstet Gynecol Scand; 1974; 53(2):155-9. PubMed ID: 4362662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of standard-dose and low-dose oral contraceptives in rural Bangladesh.
    Bairagi R; Razzaque A; Obaidullah M; Measham AR; Khan AR
    Int J Gynaecol Obstet; 1980; 18(4):264-7. PubMed ID: 6109670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovulation inhibition following vaginal administration of pills containing norethindrone and mestranol.
    Coutinho EM; Silva AR; Carreira C; Barbosa I
    Contraception; 1984 Feb; 29(2):197-202. PubMed ID: 6723313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pelvic congestive effects of norethindorne plus mestranol.
    Boatwright B; Kaufman RH
    Fertil Steril; 1968; 19(2):161-71. PubMed ID: 5640704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.